Effect of Swimming on Premenstrual Syndrome

August 25, 2017 updated by: Ahmed Maged, Cairo University

Effect of Aeropbic Exercise as Swimming on Premenstrual Syndrome

Each female sets her experience of 47 manifestations on a 6 point scale separately for the premenstrual, menstrual and intermenstrual phases of her latest and worst menstrual cycle. Daily Symptoms Report was filled at the start and at end of the study (before and after performing swimming exercise) Females in group I were instructed to engage into swimming exercise 30 minutes daily, 3 times weekly for 3 months. Exercise was ceased on the first 3 days of menstrual cycle then resumed afterwards.

The exercise included three stages: warming up, swimming and cooling down.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

Each female sets her experience of 47 manifestations on a 6 point scale separately for the premenstrual, menstrual and intermenstrual phases of her latest and worst menstrual cycle. Daily Symptoms Report was filled at the start and at end of the study (before and after performing swimming exercise) Females in group I were instructed to engage into swimming exercise 30 minutes daily, 3 times weekly for 3 months. Exercise was ceased on the first 3 days of menstrual cycle then resumed afterwards.

The exercise included three stages: warming up, swimming and cooling down. Warming up phase involved 5 minutes of breathing, circulatory and stretching exercises. Breathing diaphragmatic and costal exercise was performed. Diaphragmatic breathing exercise was performed at a convenient position with full relaxation, then she inspires deeply through the nose, ballooning her abdomen then expires through the mouth with a sigh and slowly and that was repeated 3-5 times.

Costal breathing exercise was done also at the woman favorable position then she inspires deeply through the nose, opens out her ribs then expires through the mouth with a sigh and slowly and that was repeated 3-5 times..

Circulatory foot and ankle exercises were done by instructing the woman to point her toes up and down, doing isometric calf muscle contractions and knee flexion and extension.

Stretching exercise of neck flexors, extensors, latissimus dorsi, Deltoid dorsal fibers, triceps, pectoralis major, supraspinatus, wrist , lumbar extensors, abdominal, lumbar flexors, lumbar rotators, hamstrings, adductor, gluteal, gastrocnemius, hip flexors, tensor fascia latae and quadriceps muscles were performed during warming up phase.

The second phase of treatment was swimming for 20 minutes starting with 5 minutes walking inside the pool around its edges, then forth and back swimming without reaching fatigue level for 15 minutes.

The last phase was cooling down phase which was the same exercises of the warming up phase for 5 minutes

Study Type

Interventional

Enrollment (Actual)

70

Phase

  • Not Applicable

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Cairo, Egypt, 12151
        • Kasr Alainy Medical School

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

18 years to 25 years (Adult)

Accepts Healthy Volunteers

No

Genders Eligible for Study

Female

Description

Inclusion Criteria:

  1. virgins.
  2. Their age ranged from 18 to 25 years old
  3. Their body mass index (BMI) ranged from 18 to 25 kg/m2.
  4. They were clinically and medically stable during the study
  5. Have regular menstrual cycle of 23 to 35 days duration

Exclusion Criteria:

  1. cardiopulmonary or orthopaedic problems
  2. women taking any hormonal drugs or drugs that affect hormones as antidepressnats during the preceding 3 months before participation in the study
  3. any abnormality in ovulation or those with pelvic inflammatory diseases (PID).
  4. Women with endocrine abnormality as thyroid, pituitary or ovarian disorders

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

  • Primary Purpose: Treatment
  • Allocation: Randomized
  • Interventional Model: Parallel Assignment
  • Masking: None (Open Label)

Arms and Interventions

Participant Group / Arm
Intervention / Treatment
Active Comparator: Swimming group

Females in group I were instructed to engage into swimming exercise 30 minutes daily, 3 times weekly for 3 months. Exercise was ceased on the first 3 days of menstrual cycle then resumed afterwards.

The exercise included three stages: warming up, swimming and cooling down.

Females in group I were instructed to engage into swimming exercise 30 minutes daily, 3 times weekly for 3 months. Exercise was ceased on the first 3 days of menstrual cycle then resumed afterwards.

The exercise included three stages: warming up, swimming and cooling down.

Other Names:
  • Swimming
No Intervention: Non swimming group
no intervention

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Premenstrual distress questionnaire
Time Frame: 3 months after start of swimming
47 manifestations on a 6 point scale separately for the premenstrual, menstrual and intermenstrual phases of her latest and worst menstrual cycle. Daily Symptoms Report was filled at the start and at end of the study (before and after performing swimming exercise)
3 months after start of swimming

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Publications and helpful links

The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

April 3, 2016

Primary Completion (Actual)

May 14, 2017

Study Completion (Actual)

August 12, 2017

Study Registration Dates

First Submitted

August 25, 2017

First Submitted That Met QC Criteria

August 25, 2017

First Posted (Actual)

August 29, 2017

Study Record Updates

Last Update Posted (Actual)

August 29, 2017

Last Update Submitted That Met QC Criteria

August 25, 2017

Last Verified

August 1, 2017

More Information

Terms related to this study

Other Study ID Numbers

  • 10

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

UNDECIDED

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Premenstrual Syndrome

Clinical Trials on Aerobic exercise

Subscribe